Thrombopoietin receptor agonist is more effective than platelet transfusion for chronic liver disease with thrombocytopenia, shown by propensity score matching-Reference-Cited by-同舟云学术

Thrombopoietin receptor agonist is more effective than platelet transfusion for chronic liver disease with thrombocytopenia, shown by propensity score matching

Published:2020-06-30 Issue:9 Volume:50 Page:1062-1070
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Furuichi Yoshihiro¹^ORCID,Takeuchi Hirohito¹^ORCID,Yoshimasu Yuu¹^ORCID,Kasai Yoshitaka¹^ORCID,Abe Masakazu¹^ORCID,Itoi Takao¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13530

Reference20 articles.

1. Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis

2. Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease

3. Clinical predictors of bleeding esophageal varices in the ED

4. Non-infectious complications of transfusion therapy

5. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Compared with Platelet Transfusion;Digestive Diseases;2024-04-25

2. Variceal ligation in decompensated cirrhosis before esophageal endoscopic submucosal dissection;VideoGIE;2022-12

3. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study;World Journal of Gastrointestinal Surgery;2022-11-27

4. Dualistic role of platelets in living donor liver transplantation: Are they harmful?;World Journal of Gastroenterology;2022-03-07

5. Lusutrombopag has slightly stronger effects on patients with mild thrombocytopenia compared with those with severe thrombocytopenia: A multicenter propensity score matching study;Journal of Hepato-Biliary-Pancreatic Sciences;2022-01-08